Prostate cancer is the most common cancer and the second leading cause of cancer deaths among men in the U.S. Epidemiological data and segregation analyses support the hypothesis that genetic components contribute strongly to susceptibility, particularly in men diagnosed at younger ages or men with a family history of disease. We have conducted a genome-wide scan of 254 high-risk prostate cancer families collected, characterized, and genotyped largely in the past 3 years. We now propose to utilize the resulting data to identify putative susceptibility genes through the following aims. Initially, we will assign priorities for follow-up of provocative regions by refined mapping. Analyses derived from the entire data set as well as stratified subsets of families grouped by age at onset, family history, and clinical features of disease will be considered. Regions for which the most compelling and consistent data are observed using a set of stated criteria will be selected for detailed follow-up and verification. Once loci of interest are prioritized, we will define a minimum critical region for each by genotyping additional markers and identifying recombinants relative to markers and known genes. A physical map of BACs across regions of interest will be constructed using publicly available data, with gaps filled In by additional screening and sequencing as needed. Oligoarrays of exons across the minimum region will then be constructed and probed with mRNA isolated from both normal prostate and tumor to identify genes from the region of interest. Additional information will likely be derived from analysis of tumors from putatively linked families on the same oligoarrays. Final selection of candidate genes will be made using array data, functional information, and publicly available expression data. Full-length cDNA clones will be isolated and sequenced as needed. These genes, together with any identified by other investigators, will be fully analyzed for disease-associated mutations and polymorphisms, including SNPs, in the 254 family data set. The resulting data will provide information about the type and distribution of mutations in high-risk families as well as provide useful information for understanding genetic heterogeneity of prostate cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA078836-05
Application #
6624071
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Seminara, Daniela
Project Start
1999-04-01
Project End
2006-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
5
Fiscal Year
2003
Total Cost
$549,643
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Bailey-Wilson, Joan E; Childs, Erica J; Cropp, Cheryl D et al. (2012) Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. BMC Med Genet 13:46
Lu, Lingyi; Cancel-Tassin, Geraldine; Valeri, Antoine et al. (2012) Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. Prostate 72:410-26
Christensen, G Bryce; Baffoe-Bonnie, Agnes B; George, Asha et al. (2010) Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate 70:735-44
Schaid, Daniel J; McDonnell, Shannon K; Carlson, Erin E et al. (2008) Searching for epistasis and linkage heterogeneity by correlations of pedigree-specific linkage scores. Genet Epidemiol 32:464-75
Tischkowitz, Marc D; Yilmaz, Ahmet; Chen, Long Q et al. (2008) Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer. Cancer Lett 270:173-80
Johanneson, Bo; McDonnell, Shannon K; Karyadi, Danielle M et al. (2008) Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb. Hum Genet 123:65-75
Camp, Nicola J; Cannon-Albright, Lisa A; Farnham, James M et al. (2007) Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet 16:1271-8
Bianchi-Frias, Daniella; Pritchard, Colin; Mecham, Brigham H et al. (2007) Genetic background influences murine prostate gene expression: implications for cancer phenotypes. Genome Biol 8:R117
Schaid, Daniel J; McDonnell, Shannon K; Carlson, Erin E et al. (2007) Affected relative pairs and simultaneous search for two-locus linkage in the presence of epistasis. Genet Epidemiol 31:431-49
Johanneson, Bo; Deutsch, Kerry; McIntosh, Laura et al. (2007) Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer. Prostate 67:732-42

Showing the most recent 10 out of 21 publications